Deep Tech Startups

NeoEarth develops performance improvements for industrial microalgae strains, combining microalgae biology research with cultivation and production process development. It works to scale industrial collaborations and partnerships around microalgae engineering.

2 investors

NeoBe Therapeutics develops engineered live biotherapeutics for oncology, combining synthetic biology and immunology to create next-generation cell therapies. The company serves cancer patients through collaborations with leading academic institutions and investors.

2 investors

Neolens builds technology tools to help mechanics maintain foreign-made military equipment, developed through customer discovery with defense stakeholders. The company was founded to serve defense and military maintenance needs, with early work focused on supporting Ukrainian mechanics.

2 investors

NeoLogic develops semiconductor and VLSI design solutions for chip design and fabrication. The company provides engineering expertise and services in processor design, physical implementation, and silicon product commercialization across various process nodes and industries.

2 investors

Neoteny is an early-stage venture capital firm focused on investing in startups, with a particular emphasis on technologies addressing complex problems such as climate change and societal inequity. The firm is led by founder Joichi "Joi" Ito, who brings experience as an entrepreneur, scholar, and early investor in companies including Flickr, Kickstarter, and Twitter.

2 investors

Neptune Nanotechnologies produces chitin nanocrystals derived from discarded crustacean shells as a sustainable additive to enhance performance in pulp and paper, epoxy resins, and packaging applications. The company serves industries seeking to replace petroleum-based and synthetic additives with biodegradable, high-performance alternatives.

2 investors

NervGen is a clinical-stage biotech company developing therapies for neurological conditions, with a focus on spinal cord injury and neurorepair. It maintains a drug pipeline and operates as a publicly traded company.

2 investors

Neuphonic builds ultra-low latency text-to-speech models for real-time AI voice interactions that run on-device without internet connectivity. The company develops open-source AI voice technology enabling developers to build voice-native applications.

2 investors

Neural Dynamics Technologies develops neural interface technology aimed at advancing neuroscience research and treating neurological diseases. The company brings together neuroscientists, engineers, and clinicians in an interdisciplinary approach.

2 investors

Neuraptive is a biotechnology company staffed by professionals with expertise in research and development, manufacturing, and commercialization in the pharmaceutical industry.

2 investors

Neuraspace develops AI and machine learning models to predict satellite collisions and manage space debris for satellite operators and space agencies. The company aims to enable safe and automated space operations while maintaining a sustainable orbital environment.

2 investors

NeuraWorx is developing a wearable bioelectronic stimulator based on its Cerebrovascular Pacing System, intended for sale after clinical study and FDA clearance. The device is a neurostimulation medical technology in early development.

2 investors

neuro42 develops a portable, FDA 510(k)-cleared MRI platform that brings neurological imaging directly to the patient rather than requiring transport to a facility. The system supports point-of-care diagnosis and image-guided, minimally invasive neurological procedures for physicians and patients.

2 investors

NeuroEquilibrium operates a network of clinics specializing in diagnosis and treatment of vertigo, dizziness, and balance disorders through a deep-tech platform that integrates cloud technology, computer vision, and remote diagnostics. The company serves patients and healthcare providers in India and globally, aiming to standardize care for vestibular disorders.

2 investors

Neurogene develops gene therapy treatments for rare neurological diseases. The company aims to make severe genetic neurological conditions treatable for patients and families impacted by these conditions.

2 investors

Neuroharmonics is developing a non-invasive neuromodulation platform based on focused transcranial ultrasound to modulate specific brain circuits for treating neurological and psychiatric conditions and enabling brain-computer interaction. The company operates in the neurotech and medical technology space.

2 investors

Neurolase develops AI-powered technology for brain surgery, aiming to improve surgical precision and patient outcomes in neurosurgery, particularly for brain tumor resection. The company is built by a team of clinicians, scientists and engineers to set a new intraoperative standard for neurosurgeons.

2 investors

NeuroVasc Technologies develops catheter-based medical devices designed to treat stroke and other neurological conditions. The company serves patients and healthcare providers requiring neurovascular interventions.

2 investors

Newlab is a technology innovation hub and operator that works with founders building critical technologies, providing expertise, infrastructure, and commercialization support across climate, energy, materials, and deeptech sectors.

2 investors

NewOrbit designs and builds satellites for very-low Earth orbit to advance global connectivity and earth observation. The company works to unlock the potential of Earth's lowest orbit while maintaining space sustainability.

2 investors

Nexdot develops quantum dots and quantum plates—fluorescent nanocrystals—for industrial applications in displays, lighting, energy storage, and infrared detection. The company also produces UV-protective coatings (Uvltimate) for fragrance and cosmetic products to replace harmful additives.

2 investors

NexMR, an ETH Zurich spin-off, develops light-coupled NMR hardware, consumables, and automated analysis software to increase throughput and reduce resource use in NMR-based drug discovery pipelines. Its sensitivity-enhanced technology targets early-stage drug discovery workflows, including hit affinity determination and screening of challenging targets.

2 investors

Anthriq (Nexstem) is building a "Human Body API," a full-stack platform of hardware and software for reading and interpreting human biosignals and psychophysiology. It provides infrastructure and tools for innovators developing brain-computer interface (BCI) and human-computer interface (HCI) products.

2 investors

Next Ocean provides a DNV-validated system that scans the sea surface to predict incoming waves and the resulting vessel or floating-platform motions minutes in advance, reducing wave- and motion-related risks for offshore operations. It targets offshore operators seeking safer, more efficient execution of activities such as ROV deployment.

2 investors